PNC Financial Services Group’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$247K Buy
16,960
+1,373
+9% +$13.2K ﹤0.01% 2306
2026
Q1
$116K Sell
15,587
-889
-5% -$9.35K ﹤0.01% 2711
2025
Q4
$194K Sell
16,476
-1,619
-9% -$17.5K ﹤0.01% 2336
2025
Q3
$140K Buy
18,095
+2,565
+17% +$18K ﹤0.01% 2558
2025
Q2
$114K Buy
15,530
+11,175
+257% +$90.2K ﹤0.01% 2625
2025
Q1
$41.3K Sell
4,355
-11,255
-72% -$141K ﹤0.01% 3204
2024
Q4
$257K Buy
15,610
+770
+5% +$12K ﹤0.01% 2019
2024
Q3
$219K Sell
14,840
-1,100
-7% -$17.2K ﹤0.01% 2118
2024
Q2
$221K Sell
15,940
-4,603
-22% -$65.3K ﹤0.01% 2070
2024
Q1
$323K Buy
20,543
+12,109
+144% +$187K ﹤0.01% 1835
2023
Q4
$136K Buy
8,434
+1,791
+27% +$29.3K ﹤0.01% 2411
2023
Q3
$81.7K Sell
6,643
-904
-12% -$13.4K ﹤0.01% 2694
2023
Q2
$121K Sell
7,547
-892
-11% -$14.7K ﹤0.01% 2523
2023
Q1
$147K Buy
8,439
+613
+8% +$8.73K ﹤0.01% 2336
2022
Q4
$72.3K Sell
7,826
-9,084
-54% -$84.7K ﹤0.01% 2771
2022
Q3
$145K Buy
16,910
+6,057
+56% +$60.2K ﹤0.01% 2302
2022
Q2
$88K Sell
10,853
-7,904
-42% -$75.5K ﹤0.01% 2662
2022
Q1
$228K Sell
18,757
-7,332
-28% -$154K ﹤0.01% 2169
2021
Q4
$890K Sell
26,089
-2,089
-7% -$81.8K ﹤0.01% 1354
2021
Q3
$1.36M Buy
28,178
+1,910
+7% +$88.4K ﹤0.01% 1048
2021
Q2
$1.19M Buy
26,268
+126
+0.5% +$5.58K ﹤0.01% 1126
2021
Q1
$1.26M Sell
26,142
-1,314
-5% -$68.4K ﹤0.01% 1066
2020
Q4
$1.48M Sell
27,456
-9,536
-26% -$431K ﹤0.01% 968
2020
Q3
$1.36M Buy
36,992
+1,636
+5% +$60.8K ﹤0.01% 924
2020
Q2
$1.1M Buy
35,356
+9,336
+36% +$259K ﹤0.01% 993
2020
Q1
$718K Sell
26,020
-1,304
-5% -$39.1K ﹤0.01% 1115
2019
Q4
$799K Buy
27,324
+9,584
+54% +$228K ﹤0.01% 1194
2019
Q3
$340K Sell
17,740
-18,773
-51% -$440K ﹤0.01% 1820
2019
Q2
$800K Sell
36,513
-928
-2% -$20.4K ﹤0.01% 1375
2019
Q1
$766K Buy
37,441
+4,489
+14% +$78K ﹤0.01% 1415
2018
Q4
$416K Sell
32,952
-20,000
-38% -$298K ﹤0.01% 1646
2018
Q3
$813K Buy
52,952
+32,200
+155% +$445K ﹤0.01% 1436
2018
Q2
$272K Buy
+20,752
New +$228K ﹤0.01% 2007
2016
Q3
Sell
-387
Closed -$3K 4173
2016
Q2
$3K Sell
387
-15
-4% -$120 ﹤0.01% 4045
2016
Q1
$3K Buy
402
+14
+4% +$92 ﹤0.01% 4057
2015
Q4
$3K Buy
+388
New +$2.84K ﹤0.01% 4048
2014
Q4
Sell
-300
Closed -$2K 4221
2014
Q3
$2K Buy
+300
New +$1.54K ﹤0.01% 3674

Other funds holding NEO

PNC Financial Services Group's NEO Position: Q2 2026 in Review

PNC Financial Services Group increased its NeoGenomics (NEO) stake by 8.8% in Q2 2026, buying an estimated $13.2K and bringing the position to 16,960 shares worth $247K. The position accounts for ﹤0.01% of the portfolio, ranked #2306.

PNC Financial Services Group first reported a position in NEO in Q3 2014 and has held it in 37 quarters since. The position peaked at $1.48M in Q4 2020. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • PNC Financial Services Group held 16,960 shares of NeoGenomics worth $247K as of Q2 2026.
  • PNC Financial Services Group bought 1,373 NeoGenomics shares in Q2 2026, an estimated $13.2K.
  • NeoGenomics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #2306 holding.
  • PNC Financial Services Group first reported a position in NeoGenomics in Q3 2014 and has held it in 37 quarters since.
  • PNC Financial Services Group's NeoGenomics position peaked at $1.48M in Q4 2020.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.